Related references
Note: Only part of the references are listed.Extended-release calcifediol in stage 3-4 chronic kidney disease: a new therapy for the treatment of secondary hyperparathyroidism associated with hypovitaminosis D
Mario Cozzolino et al.
JOURNAL OF NEPHROLOGY (2022)
Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism
Charles W. Bishop et al.
AMERICAN JOURNAL OF NEPHROLOGY (2022)
Impact of nutritional vitamin D supplementation on parathyroid hormone and 25-hydroxyvitamin D levels in non-dialysis chronic kidney disease: a meta-analysis
Jordi Bover et al.
CLINICAL KIDNEY JOURNAL (2021)
Real-World Assessment: Clinical Effectiveness and Safety of Extended-Release Calcifediol
George Fadda et al.
AMERICAN JOURNAL OF NEPHROLOGY (2021)
Con: Nutritional vitamin D replacement in chronic kidney disease and end-stage renal disease (vol 31, pg 706, 2016)
Rajiv Agarwal et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)
Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease
Stephen A. Strugnell et al.
AMERICAN JOURNAL OF NEPHROLOGY (2019)
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Foreword
David C. Wheeler et al.
KIDNEY INTERNATIONAL SUPPLEMENTS (2017)
Extended-release calcifediol for secondary hyperparathyroidism in stage 3-4 chronic kidney disease
Stuart M. Sprague et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2017)
Con: Nutritional vitamin D replacement in chronic kidney disease and end-stage renal disease
Rajiv Agarwal et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Effect of Paricalcitol on Left Ventricular Mass and Function in CKD-The OPERA Trial
Angela Yee-Moon Wang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
The Importance of Body Weight for the Dose Response Relationship of Oral Vitamin D Supplementation and Serum 25-Hydroxyvitamin D in Healthy Volunteers
John Paul Ekwaru et al.
PLOS ONE (2014)
Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease
Ian H. de Boer et al.
KIDNEY INTERNATIONAL (2013)
Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links
A. Fisher et al.
CLINICAL INTERVENTIONS IN AGING (2013)
Paricalcitol Versus Ergocalciferol for Secondary Hyperparathyroidism in CKD Stages 3 and 4: A Randomized Controlled Trial
Csaba P. Kovesdy et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Secondary Hyperparathyroidism: Pathogenesis, Disease Progression, and Therapeutic Options
John Cunningham et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Quality of life in patients with chronic kidney disease
Maria Carolina Cruz et al.
CLINICS (2011)
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice
Jean-Claude Souberbielle et al.
AUTOIMMUNITY REVIEWS (2010)
Control of Secondary Hyperparathyroidism by Vitamin D Receptor Agonists in Chronic Kidney Disease
Stuart M. Sprague et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Responses of parathyroid hormone to vitamin D supplementation: A systematic review of clinical trials
Mikko Bjorkman et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2009)
Vitamin D levels and patient outcome in chronic kidney disease
Pietro Ravani et al.
KIDNEY INTERNATIONAL (2009)
Association of Secondary Hyperparathyroidism with CKD Progression, Health Care Costs and Survival in Diabetic Predialysis CKD Patients
Glen T. Schumock et al.
NEPHRON CLINICAL PRACTICE (2009)
Impact of secondary hyperparathyroidism on disease progression, healthcare resource utilization and costs in pre-dialysis CKD patients
Glen T. Schumock et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Secondary hyperparathyroidism is associated with higher cost of care among chronic kidney disease patients with cardiovascular comorbidities
Samina Khan
NEPHRON CLINICAL PRACTICE (2007)
Health-related quality of life and estimates of utility in chronic kidney disease
I Gorodetskaya et al.
KIDNEY INTERNATIONAL (2005)
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
GA Block et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Secondary hyperparathyroidism: Review of the disease and its treatment
ALM de Francisco
CLINICAL THERAPEUTICS (2004)
Share Paper
